Eric Drape is VP at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). They have made 11 open-market trades across 1 company since 2020, most recently 2024-03-05.
CIK 0001790905
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TEVA | 90,689 | $3.8M |
Shares reported on the most recent Form 4, priced at the 2024-03-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TEVA | SELL · 10b5-1 | 2024-02-28 | 2024-03-01 | $13.12 | $258K | +0.5% | +2.4% | +24.4% |
| TEVA | SELL | 2024-02-16 | 2024-02-21 | $13.05 | $4.5M | +3.0% | +6.4% | +27.1% |
| TEVA | SELL · 10b5-1 | 2023-03-06 | 2023-03-08 | $9.55 | $60K | -11.5% | -2.4% | -25.0% |
| TEVA | SELL | 2023-02-28 | 2023-03-02 | $9.89 | $666K | -10.9% | -8.8% | -28.0% |
| TEVA | SELL | 2022-03-04 | 2022-03-08 | $7.44 | $471K | +4.1% | +34.3% | +19.5% |
| TEVA | SELL | 2022-02-28 | 2022-03-02 | $8.14 | $159K | -7.2% | +18.7% | +15.0% |
| TEVA | SELL · 10b5-1 | 2022-02-09 | 2022-02-10 | $9.06 | $32K | -9.0% | -16.6% | -16.2% |
| TEVA | SELL | 2021-05-21 | 2021-05-25 | $11.01 | $440K | +2.4% | -0.8% | -10.7% |
| TEVA | SELL | 2021-05-11 | 2021-05-13 | $10.22 | $405K | -0.2% | +5.2% | -3.0% |
| TEVA | SELL | 2021-03-04 | 2021-03-08 | $10.58 | $131K | +5.6% | +5.0% | -0.5% |
| TEVA | SELL | 2021-03-01 | 2021-03-02 | $10.85 | $213K | -0.1% | +6.3% | -2.8% |
| TEVA | SELL · 10b5-1 | 2021-02-16 | 2021-02-17 | $11.13 | $23K | -2.2% | +3.1% | -4.5% |
| TEVA | SELL | 2021-02-09 | 2021-02-11 | $12.72 | $413K | +0.2% | -1.3% | -9.1% |
| TEVA | SELL | 2020-02-19 | 2020-02-20 | $12.51 | $100K | -15.0% | -43.2% | -9.0% |
| TEVA | SELL | 2020-02-14 | 2020-02-18 | $12.14 | $175K | -7.9% | -42.7% | -6.0% |
| TEVA | SELL · 10b5-1 | 2020-02-10 | 2020-02-11 | $12.24 | $38K | -3.0% | -40.4% | -12.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.